These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 17691482)
1. [Metabotropic glutamate receptors as a possible target of antiepileptic therapy]. Lojková D; Mares P Cesk Fysiol; 2007; 56(2):60-8. PubMed ID: 17691482 [TBL] [Abstract][Full Text] [Related]
2. Glutamate metabotropic receptors as targets for drug therapy in epilepsy. Moldrich RX; Chapman AG; De Sarro G; Meldrum BS Eur J Pharmacol; 2003 Aug; 476(1-2):3-16. PubMed ID: 12969743 [TBL] [Abstract][Full Text] [Related]
3. Regulation of spontaneous Ca(2+) spikes by metabotropic glutamate receptors in primary cultures of rat cortical neurons. Koga K; Iwahori Y; Ozaki S; Ohta H J Neurosci Res; 2010 Aug; 88(10):2252-62. PubMed ID: 20209633 [TBL] [Abstract][Full Text] [Related]
4. Excitatory aminoacids and epileptic seizures in immature brain. Mares P; Folbergrová J; Kubová H Physiol Res; 2004; 53 Suppl 1():S115-24. PubMed ID: 15119942 [TBL] [Abstract][Full Text] [Related]
5. Age-dependent anticonvulsant action of antagonists of group I glutamate metabotropic receptors in rats. Mares P Epilepsy Res; 2009 Feb; 83(2-3):215-23. PubMed ID: 19097860 [TBL] [Abstract][Full Text] [Related]
6. Modulation of Chronic Pain by Metabotropic Glutamate Receptors. Chiechio S Adv Pharmacol; 2016; 75():63-89. PubMed ID: 26920009 [TBL] [Abstract][Full Text] [Related]
7. Anticonvulsant action of an antagonist of metabotropic glutamate receptors mGluR5 MPEP in immature rats. Lojková D; Mares P Neuropharmacology; 2005; 49 Suppl 1():219-29. PubMed ID: 15950993 [TBL] [Abstract][Full Text] [Related]
8. Metabotropic glutamate receptors in the control of neuronal activity and as targets for development of anti-epileptogenic drugs. Tang FR; Bradford HF; Ling EA Curr Med Chem; 2009; 16(17):2189-204. PubMed ID: 19519386 [TBL] [Abstract][Full Text] [Related]
9. Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy. Alexander GM; Godwin DW Epilepsy Res; 2006 Sep; 71(1):1-22. PubMed ID: 16787741 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of glutamate uptake mediates the neuroprotection exerted by activating group II or III metabotropic glutamate receptors on astrocytes. Yao HH; Ding JH; Zhou F; Wang F; Hu LF; Sun T; Hu G J Neurochem; 2005 Feb; 92(4):948-61. PubMed ID: 15686497 [TBL] [Abstract][Full Text] [Related]
11. Positive and negative modulation of circadian activity rhythms by mGluR5 and mGluR2/3 metabotropic glutamate receptors. Gannon RL; Millan MJ Neuropharmacology; 2011; 60(2-3):209-15. PubMed ID: 20831878 [TBL] [Abstract][Full Text] [Related]
12. In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists. Suzuki G; Tsukamoto N; Fushiki H; Kawagishi A; Nakamura M; Kurihara H; Mitsuya M; Ohkubo M; Ohta H J Pharmacol Exp Ther; 2007 Oct; 323(1):147-56. PubMed ID: 17609420 [TBL] [Abstract][Full Text] [Related]
13. Orthosteric versus allosteric GPCR activation: the great challenge of group-III mGluRs. Flor PJ; Acher FC Biochem Pharmacol; 2012 Aug; 84(4):414-24. PubMed ID: 22554564 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC). Suzuki G; Kimura T; Satow A; Kaneko N; Fukuda J; Hikichi H; Sakai N; Maehara S; Kawagoe-Takaki H; Hata M; Azuma T; Ito S; Kawamoto H; Ohta H J Pharmacol Exp Ther; 2007 Jun; 321(3):1144-53. PubMed ID: 17360958 [TBL] [Abstract][Full Text] [Related]
15. [Metabotropic glutamate receptor 8 activation promotes the apoptosis of lung carcinoma A549 cells in vitro]. Li TJ; Huang YH; Chen X; Zhou Z; Luo SW; Feng DD; Han JZ; Luo ZQ Sheng Li Xue Bao; 2015 Oct; 67(5):513-20. PubMed ID: 26490069 [TBL] [Abstract][Full Text] [Related]
17. Anatomy and function of group III metabotropic glutamate receptors in gastric vagal pathways. Young RL; Cooper NJ; Blackshaw LA Neuropharmacology; 2008 May; 54(6):965-75. PubMed ID: 18371991 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of metabotropic glutamate receptor group II and III activators against MPP(+)-induced cell death in human neuroblastoma SH-SY5Y cells: the impact of cell differentiation state. Jantas D; Greda A; Golda S; Korostynski M; Grygier B; Roman A; Pilc A; Lason W Neuropharmacology; 2014 Aug; 83():36-53. PubMed ID: 24713472 [TBL] [Abstract][Full Text] [Related]
19. L-homocysteine sulfinic acid and other acidic homocysteine derivatives are potent and selective metabotropic glutamate receptor agonists. Shi Q; Savage JE; Hufeisen SJ; Rauser L; Grajkowska E; Ernsberger P; Wroblewski JT; Nadeau JH; Roth BL J Pharmacol Exp Ther; 2003 Apr; 305(1):131-42. PubMed ID: 12649361 [TBL] [Abstract][Full Text] [Related]
20. Kindled seizures increase metabotropic glutamate receptor expression and function in the rat supraoptic nucleus. Al-Ghoul WM; Meeker RB; Greenwood RS J Neurosci Res; 1998 Nov; 54(3):412-23. PubMed ID: 9819146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]